Results 201 to 210 of about 558,623 (254)
Early-Onset Neonatal Infection and Cerebral Palsy.
Andersen M +4 more
europepmc +1 more source
Swallowing Muscle Ultrasonography in Children With Cerebral Palsy and Dysphagia: A Cross-Sectional Study. [PDF]
Akaltun MS, Alyanak B, Umay E.
europepmc +1 more source
ABSTRACT Aim School performance requires a wide spectrum of developmental abilities including cognitive, social and behavioural skills. We aimed to study the association between developmental difficulties at 5 years and the received school support services at 8 and 11 years in children born very preterm.
Eeva Mäkilä +34 more
wiley +1 more source
Effects of an Intensive Gait Training Rehabilitation Protocol After Single Event Multilevel Surgery in Cerebral Palsy: Activ'Marche. [PDF]
Ayoubi F +11 more
europepmc +1 more source
ABSTRACT Aim Postnatally acquired cytomegalovirus (pCMV) infection may cause severe disease in extremely preterm infants, but its clinical significance remains uncertain. We investigated the incidence, timing, disease burden, and diagnostic performance of saliva screening. Method In this prospective cohort study, infants born at < 28 weeks of gestation
Sara Krøis Holm +16 more
wiley +1 more source
Virtual Reality-Assisted Rehabilitation for Adolescents with Cerebral Palsy: A Systematic Review and Meta-Analysis. [PDF]
Chen TW, Lin YC.
europepmc +1 more source
ABSTRACT Aim To examine temporal trends in cerebral palsy (CP) birth prevalence and changes in functional severity in Sweden between 2000 and 2019. Methods This population‐based registry study included all children with CP born in Sweden between 2000 and 2019. Annual CP birth prevalence was calculated using Poisson regression.
Semhal Getachew Teka +2 more
wiley +1 more source
Associations between deprivation and postneonatal cerebral palsy over 35 years: a population-based longitudinal study. [PDF]
Perra O, Keenan R, Kerr C.
europepmc +1 more source
Summary B‐cell maturation antigen‐directed chimeric antigen receptor (CAR) T cells have revolutionized the treatment of relapsed/refractory multiple myeloma. However, no randomized head‐to‐head comparison of idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) is available, and real‐world data suggest differences in efficacy and ...
Irene Strassl +23 more
wiley +1 more source

